Insider Trading Alert - IT, CLB And ALTR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 6, 2014, 101 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $393.74 to $268,715,620.68.

Highlighted Stocks Traded by Insiders:

Gartner (IT) - FREE Research Report

Kranich Robin B who is SVP, Human Resource at Gartner sold 4,162 shares at $70.08 on March 6, 2014. Following this transaction, the SVP, Human Resource owned 33,568 shares meaning that the stake was reduced by 11.03% with the 4,162-share transaction.

The shares most recently traded at $72.39, up $2.31, or 3.19% since the insider transaction. Historical insider transactions for Gartner go as follows:

  • 4-Week # shares sold: 6,384
  • 12-Week # shares sold: 6,384
  • 24-Week # shares sold: 208,000

The average volume for Gartner has been 478,100 shares per day over the past 30 days. Gartner has a market cap of $6.6 billion and is part of the technology sector and computer software & services industry. Shares are up 0.62% year-to-date as of the close of trading on Thursday.

Gartner, Inc. provides independent and objective research and analysis on information technology (IT), computer hardware, software, communications, and related technology industries. The company has a P/E ratio of 37.0. Currently there are 5 analysts that rate Gartner a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IT - FREE

TheStreet Quant Ratings rates Gartner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Gartner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Core Laboratories N.V (CLB) - FREE Research Report

Dunlap Charles L who is Director at Core Laboratories N.V bought 200 shares at $187.70 on March 6, 2014. Following this transaction, the Director owned 300 shares meaning that the stake was reduced by 200% with the 200-share transaction.

The shares most recently traded at $192.54, up $4.84, or 2.51% since the insider transaction. Historical insider transactions for Core Laboratories N.V go as follows:

  • 4-Week # shares bought: 200
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 200
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 200
  • 24-Week # shares sold: 7,204

The average volume for Core Laboratories N.V has been 264,500 shares per day over the past 30 days. Core Laboratories N.V has a market cap of $8.5 billion and is part of the basic materials sector and energy industry. Shares are down 0.93% year-to-date as of the close of trading on Thursday.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the Netherlands and internationally. The company operates in three segments: Reservoir Description, Production Enhancement, and Reservoir Management. The stock currently has a dividend yield of 1.06%. The company has a P/E ratio of 35.8. Currently there are 3 analysts that rate Core Laboratories N.V a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLB - FREE

TheStreet Quant Ratings rates Core Laboratories N.V as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, impressive record of earnings per share growth and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Core Laboratories N.V Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Altera (ALTR) - FREE Research Report

Schuelke Katherine who is Sr VP, GC & Secretary at Altera sold 5,000 shares at $36.22 on March 6, 2014. Following this transaction, the Sr VP, GC & Secretary owned 39,307 shares meaning that the stake was reduced by 11.28% with the 5,000-share transaction.

The shares most recently traded at $36.62, up $0.40, or 1.09% since the insider transaction. Historical insider transactions for Altera go as follows:

  • 12-Week # shares sold: 5,985
  • 24-Week # shares sold: 5,985

The average volume for Altera has been 3.3 million shares per day over the past 30 days. Altera has a market cap of $11.6 billion and is part of the technology sector and electronics industry. Shares are up 11.99% year-to-date as of the close of trading on Thursday.

Altera Corporation, a semiconductor company, designs, manufactures, and sells programmable logic devices (PLD), HardCopy application-specific integrated circuit (ASIC) devices, power system-on-chip devices (PowerSoCs), pre-defined design building blocks, and proprietary development software. The stock currently has a dividend yield of 1.65%. The company has a P/E ratio of 26.8. Currently there are 10 analysts that rate Altera a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALTR - FREE

TheStreet Quant Ratings rates Altera as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Altera Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet